Do you want to read an article? Please log in or register.
Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study
Esophagus Diseases
Related content
Inflammatory Bowel Disease
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study
BMC Gastroenterol.
Snowden JA, Hawkey C, Hind D, Swaby L, Mellor K, Emsley R, Mandefield L, Lee E, Badoglio M, Polge E, Labopin M, Gribben J, Pockley AG, Foulds GA, Lobo A, Travis S, Parkes M, Satsangi J, Papaioannou D, Lindsay JO, Autologous Stem Cell Transplantation In Refractory CD - Low Intensity Therapy Evaluation Study Investigators., European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP)
doi: 10.1186/s12876-019-0992-2.
Esophagus Diseases
Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial
Gut
Barret M, Pioche M, Terris B, Ponchon T, Cholet F, Zerbib F, Chabrun E, Le Rhun M, Coron E, Giovannini M, Caillol F, Laugier R, Jacques J, Legros R, Boustiere C, Rahmi G, Metivier-Cesbron E, Vanbiervliet G, Bauret P, Escourrou J, Branche J, Jilet L, Abdoul H, Kaddour N, Leblanc S, Bensoussan M, Prat F, Chaussade S
doi: 10.1136/gutjnl-2020-322082
ColonoscopyGastrointestinal Cancer
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study
Lancet Gastroenterol Hepatol.
Chen YX, Gao QY, Zou TH, Wang BM, Liu SD, Sheng JQ, Ren JL, Zou XP, Liu ZJ, Song YY, Xiao B, Sun XM, Dou XT, Cao HL, Yang XN, Li N, Kang Q, Zhu W, Xu HZ, Chen HM, Cao XC, Fang JY
doi: 10.1016/S2468-1253(19)30409-1.
Esophagus Diseases
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Lancet.
Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Attwood S, Ragunath K, Rameh B, Fullarton G, Tucker A, Penman I, Rodgers C, Neale J, Brooks C, Wise A, Jones S, Church N, Gibbons M, Johnston D, Vaidya K, Anderson M, Balata S, Davies G, Dickey W, Goddard A, Edwards C, Gore S, Haigh C, Harding T, Isaacs P, Jackson L, Lee T, Lim PL, Macdonald C, Mairs P, McLoughlin J, Monk D, Murdock A, Murray I, Preston S, Pugh S, Smart H, Soliman A, Todd J, Turner G, Worthingon J, Harrison R, Barr H, Moayyedi P
doi: 10.1016/S0140-6736
Esophagus Diseases
Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis
Gastrointest Endosc.
Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK
doi: 10.1016/j.gie.2018.02.021.
Esophagus Diseases
Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis
Gut.
Parasa S, Desai M, Vittal A, Chandrasekar VT, Pervez A, Kennedy KF, Gupta N, Shaheen NJ, Sharma P
doi: 10.1136/gutjnl-2018-317800.
Gallbladder and Biliary DiseasesHepatology
Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study
Hepatology
Martinez M, Perito ER, Valentino P, Mack CL, Aumar M, Broderick A, Draijer LG, Fagundes EDT, Furuya KN, Gupta N, Horslen S, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BG, Laborda TJ, Lee CK, Loomes KM, Miloh T, Mogul D, Mohammed S, Ovchinsky N, Rao G, Ricciuto A, Schwarz KB, Smolka V, Tanaka A, Tessier MEM, Venkat VL, Vitola BE, Woynarowski M, Zerofsky M, Deneau MR
doi: 10.1002/hep.31911
Esophagus Diseases
Barrett's Epithelial Thickness, Assessed by Volumetric Laser Endomicroscopy, is Associated with Response to Radiofrequency Ablation
Clin Gastroenterol Hepatol.
Levink IJM, Tearney GJ, Erler NS, Wolfsen HC, Siersema PD, Wallace MB
doi: 10.1016/j.cgh.2020.05.023.
Minimally Invasive Gastrointestinal Surgery
Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery
BMJ Open.
Edwards MR, Forbes G, MacDonald N, Berdunov V, Mihaylova B, Dias P, Thomson A, Grocott MP, Mythen MG, Gillies MA, Sander M, Phan TD, Evered L, Wijeysundera DN, McCluskey SA, Aldecoa C, Ripollés-Melchor J, Hofer CK, Abukhudair H, Szczeklik W, Grigoras I, Hajjar LA, Kahan BC, Pearse RM; OPTIMISE II investigators
doi: 10.1136/bmjopen-2018-023455.